Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management - podcast episode cover

Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management

Jun 13, 202259 minTranscript available on Metacast
--:--
--:--
Listen in podcast apps:

Episode description

We love to hear from our listeners. Send us a message.

To fully appreciate the work Pyxis Oncology is doing in its development of site-specific ADCs for a number of oncological indications under the leadership of Lara Sullivan, M.D., you need to understand the work that shaped her leadership style. On this episode of the Business of Biotech, Dr. Sullivan shares the science and technology driving progress at Pyxis, but she also serves up a master class on change management, honed during her tenure managing high-stakes product portfolios at Pfizer. If you want to be a better leader, don't miss this one. And for more on Dr. Sullivan's journey, read this recent feature story at Life Science Leader magazine.

Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.

Subscribe to our monthly Business of Biotech newsletter.

Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com

Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/